サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1425011

抗レトロウイルス薬市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測

Anti-retroviral Drugs Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 291 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
抗レトロウイルス薬市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2024年02月07日
発行: AnalystView Market Insights
ページ情報: 英文 291 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

抗レトロウイルス薬市場規模は2022年に397億9,420万米ドルとなり、2023年から2030年にかけてCAGR 5.1%で拡大

抗レトロウイルス薬市場 - 市場力学

HIVに対する負担の増加、研究開発（R&D）への投資の高まり、より効果的な新薬の利用可能性が市場の需要を促進すると予想されます。

分析対象市場の成長は、HIVの負担増加、研究開発（R&D）への投資拡大、より効果的な新薬の入手可能性など、いくつかの主要な要因によって推進されます。例えば、2022年、インドのHIV推計ファクトシートは、2021年の年間新規感染者数（ANI）が6万2,970人と推定されると報告しました。さらに、世界保健機関（WHO）は2022年7月、2021年には3,840万人がHIVとともに生活していると報告しました。特にアフリカ地域は依然として深刻な影響を受けており、成人の約25人に1人（3.4％）がHIVに感染しており、世界のHIV感染者数の3分の2以上を占めています。WHOはまた、過去20年間でHIV感染者が32.8％増加したことを強調しています。その結果、HIVの蔓延が抗レトロウイルス薬の需要に拍車をかけています。

さらに、さまざまな製薬企業による研究開発投資の増加が、市場成長の原動力となっています。その一例として、2022年6月、GSK（グラクソ・スミスクライン）は、感染症、特に低所得国に不釣り合いな影響を及ぼす感染症の治療のための研究開発活動の加速を目的とした10億ユーロの多額の投資を発表しました。GSKの研究開発は、HIV（ヴィーブヘルスケアを通じて）、マラリア、結核、その他の感染症を含む様々な疾病を予防・治療するための新しく革新的なワクチンや医薬品の開発に重点を置いています。これらの疾病は、低所得国の多くで、疾病負担の60%以上を占めています。GSKの世界ヘルスR&Dハブは、抗レトロウイルス薬の調査を含め、13の高負担感染症をターゲットに、30以上の新規ワクチンや新薬の可能性を進めています。その結果、研究開発投資の増大が研究市場拡大の大きな原動力となっています。

抗レトロウイルス薬市場 - 主要洞察

弊社のリサーチアナリストの分析によると、世界の抗レトロウイルス薬市場は予測期間（2023-2030年）にCAGR約5.1%で毎年成長すると予測されています。

抗レトロウイルス薬市場は、HIVの負担の増加、研究開発（R&D）への投資の増加、より効果的な新薬の利用可能性などを背景に、著しい速度で成長すると予測されています。

製品タイプ別では、ヌクレオシド系逆転写酵素阻害薬（NRTI）と非ヌクレオシド系逆転写酵素阻害薬（NNRTI）が2022年に最大の市場シェアを示すと予測されます。

用途別では、HIV/AIDSが2022年の主要セグメント

地域別では、北米が2022年の売上高をリード

抗レトロウイルス薬市場 -セグメンテーション分析：

世界の抗レトロウイルス薬市場は、製品タイプ、用途別、地域別に区分されます。

製品タイプに基づき、市場は4つのセグメントに分けられる：プロテアーゼ阻害剤、非ヌクレオシド系逆転写酵素阻害剤、インテグラーゼ阻害剤、ヌクレオシド類似体およびヌクレオシド系逆転写酵素阻害剤です。この分類の中では、ヌクレオシド逆転写酵素阻害剤（NRTI）と非ヌクレオシド逆転写酵素阻害剤（NNRTI）が際立っており、このセグメントに大きな成長の可能性をもたらしています。NRTIは逆転写酵素を阻害することで機能するが、NNRTIは逆転写酵素に結合し、その後に修飾します。この2つのメカニズムは、HIVがそれ自身を複製するために必要な酵素を阻害するため、この2つのタイプはウイルスとの闘いに特に効果的です。

市場は用途別に4つのセグメントに分類される：肝炎、HIV/AIDS、ヘルペス、インフルエンザ、その他です。特に抗レトロウイルス薬は、HIV/AIDSの治療に広く使用されています。米国保健社会福祉省の報告によると、世界で約3,720万人がHIV/AIDSと闘っています。

抗レトロウイルス薬市場 -地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

抗レトロウイルス薬市場 - 競合情勢：

抗レトロウイルス薬の分野では、企業は主に研究開発および商業化に注力しています。新しい抗レトロウイルス療法の発見と生産、既存の薬剤の改良、これらの薬剤の安全性と有効性を評価するための臨床試験の実施に取り組んでいます。さらに、製薬会社はしばしばヘルスケア組織や政府機関と協力し、感染地域で抗レトロウイルス治療へのアクセスを拡大しています。

目次

第1章 抗レトロウイルス薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 抗レトロウイルス薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 抗レトロウイルス薬産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 抗レトロウイルス薬市場：COVID-19感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 抗レトロウイルス薬市場情勢

  • 抗レトロウイルス薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 抗レトロウイルス薬市場 - 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • プロテアーゼ阻害剤
    • 非ヌクレオシド系逆転写酵素阻害剤
    • インテグラーゼ阻害剤
    • ヌクレオシド類似体およびヌクレオシド逆転写酵素阻害剤

第8章 抗レトロウイルス薬市場 - 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 肝炎
    • HIV/エイズ
    • ヘルペス
    • インフルエンザ
    • その他

第9章 抗レトロウイルス薬市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析 - 抗レトロウイルス薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • AbbVie Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • F. Hoffmann-La Roche Ltd
    • Gilead Sciences, Inc.
    • Merck &Co, Inc.
    • Viatris Inc.（Mylan Inc.）
    • GlaxoSmithKline plc（ViiV Healthcare）
    • Cipla Inc.
    • Johnson and Johnson

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Anti-retroviral Drugs Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Anti-retroviral Drugs Market, by Product Type 2018-2030 (USD Million)
  • TABLE Anti-retroviral Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Anti-retroviral Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Anti-retroviral Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Anti-retroviral Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Anti-retroviral Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Europe Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Latin America Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Germany Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE India Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Brazil Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2211

REPORT HIGHLIGHT

Anti-retroviral Drugs Market size was valued at USD 39,794.2 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Antiretroviral drugs are medications used to treat retroviral infections, with HIV (Human Immunodeficiency Virus) being the most prominent example. These drugs work by inhibiting the replication of the virus, thereby slowing down the progression of the disease and reducing the viral load in the body.

Anti-retroviral Drugs Market- Market Dynamics

The increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs is expected to propel the market demand

The growth of the analyzed market is propelled by several key factors, including the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs. For example, in 2022, the HIV Estimates Factsheet for India reported an estimated annual new infection (ANI) of 62.97 thousand cases in 2021. Furthermore, the World Health Organization (WHO) reported in July 2022 that 38.4 million individuals were living with HIV in 2021. The African region, in particular, remains profoundly impacted, with approximately 1 in every 25 adults (3.4%) living with HIV and contributing to over two-thirds of the global HIV-infected population. WHO also highlighted a significant 32.8% increase in HIV cases over the past two decades. Consequently, the growing prevalence of HIV is fueling the demand for antiretroviral drugs.

Moreover, increased investments in R&D by various pharmaceutical companies are a driving force behind the market's growth. As an illustration, in June 2022, GSK (GlaxoSmithKline) announced a substantial EUR 1 billion investment aimed at accelerating R&D activities for the treatment of infectious diseases, particularly those disproportionately affecting lower-income countries. GSK's research endeavors focus on the development of new and innovative vaccines and medications to prevent and treat various diseases, including HIV (via ViiV Healthcare), malaria, tuberculosis, and other infectious diseases. These diseases collectively account for over 60% of the disease burden in many lower-income nations. GSK's Global Health R&D Hubs are advancing with over 30 potential new vaccines and medications, targeting 13 high-burden infectious diseases, including antiretroviral drug research. Consequently, the augmented R&D investments are a significant driving factor behind the expansion of the studied market.

Anti-retroviral Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global Anti-retroviral Drugs Market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

The Anti-retroviral Drugs Market is projected to grow at a significant rate driven by the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs

Based on product type, the Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) was predicted to show maximum market share in the year 2022

Based on Application, HIV/AIDS was the leading Segment in 2022

On the basis of region, North America was the leading revenue generator in 2022

Anti-retroviral Drugs Market- Segmentation Analysis:

The Global Anti-retroviral Drugs Market is segmented on the basis of Product Type, By Application, and Region.

Based on the type of product, the market is divided into four segments: Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Integrase Inhibitors, and Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors. Within this classification, Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) stand out prominently, offering significant growth potential to this segment. NRTIs function by blocking reverse transcriptase, while NNRTIs bind to and subsequently modify reverse transcriptase. This dual mechanism interferes with the enzyme HIV requires to replicate itself, rendering these two types particularly effective in combating the virus.

The market is categorized by application into four segments: Hepatitis, HIV/AIDS, Herpes, Influenza, and Others. Notably, anti-retroviral drugs find extensive usage in the treatment of HIV/AIDS, primarily due to the substantial global prevalence of this disease. According to reports from the US Department of Health & Human Services, approximately 37.2 million individuals worldwide are grappling with HIV/AIDS.

Anti-retroviral Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Anti-retroviral Drugs Market- Competitive Landscape:

In the field of antiretroviral drugs, companies are primarily focused on research, development, and commercialization. They work on discovering and producing new antiretroviral therapies, improving existing medications, and conducting clinical trials to assess the safety and efficacy of these drugs. Additionally, pharmaceutical companies often collaborate with healthcare organizations and government agencies to expand access to antiretroviral treatments in affected regions.

Recent Developments:

In September 2022, Merck announced the commencement of a new phase 3 clinical trial to assess the efficacy of once-daily oral islatravir for the treatment of HIV-1 infection.

In August 2022, Gilead obtained global regulatory approval for Sunlenca (Lenacapavir), a unique twice-yearly treatment option for HIV.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-RETROVIRAL DRUGS MARKET KEY PLAYERS

  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • Merck & Co, Inc.
  • Viatris Inc. (Mylan Inc.)
  • GlaxoSmithKline plc (ViiV Healthcare)
  • Cipla Inc.
  • Johnson and Johnson

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY PRODUCT TYPE

  • Protease Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Integrase Inhibitors
  • Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY APPLICATION

  • Hepatitis
  • HIV/AIDS
  • Herpes
  • Influenza
  • Others

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Anti-retroviral Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Anti-retroviral Drugs Market Snippet by Product Type
    • 2.1.2. Anti-retroviral Drugs Market Snippet by Application
    • 2.1.3. Anti-retroviral Drugs Market Snippet by Country
    • 2.1.4. Anti-retroviral Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Anti-retroviral Drugs Key Market Trends

  • 3.1. Anti-retroviral Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Anti-retroviral Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Anti-retroviral Drugs Market Opportunities
  • 3.4. Anti-retroviral Drugs Market Future Trends

4. Anti-retroviral Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Anti-retroviral Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Anti-retroviral Drugs Market Landscape

  • 6.1. Anti-retroviral Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Anti-retroviral Drugs Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Protease Inhibitors
    • 7.1.3. Non-Nucleoside Reverse Transcriptase Inhibitors
    • 7.1.4. Integrase Inhibitors
    • 7.1.5. Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

8. Anti-retroviral Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hepatitis
    • 8.1.3. HIV/AIDS
    • 8.1.4. Herpes
    • 8.1.5. Influenza
    • 8.1.6. Others

9. Anti-retroviral Drugs Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Anti-retroviral Drugs Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Anti-retroviral Drugs Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Anti-retroviral Drugs Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Anti-retroviral Drugs Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Anti-retroviral Drugs Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Anti-retroviral Drugs Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. AbbVie Inc.
    • 10.2.2. Boehringer Ingelheim International GmbH
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. F. Hoffmann-La Roche Ltd
    • 10.2.5. Gilead Sciences, Inc.
    • 10.2.6. Merck & Co, Inc.
    • 10.2.7. Viatris Inc. (Mylan Inc.)
    • 10.2.8. GlaxoSmithKline plc (ViiV Healthcare)
    • 10.2.9. Cipla Inc.
    • 10.2.10. Johnson and Johnson

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us